GLTO
Price:
$21.58
Market Cap:
$1.31B
Galecto, Inc. is a clinical-stage biotechnology company focused on creating new therapeutic agents for a range of illnesses, including fibrotic conditions, cancer, and inflammation. Its most advanced investigational drug, GB2064, is currently undergoing Phase IIa clinical studies to treat myelofibrosis. The company is also developing GB0139, an inhalable compound that targets galectin-3, which is in Phase IIb trials for severe fibrotic lung disorders, such as idiopathic pulmonary fibrosis (IPF)—a serious and progressively worsening lung disease. Additionally, Galecto is advancing GB1211, a selective oral galectin-3 inhibitor, with ongoing Phase IIa trials for cancer and Phase Ib/IIa trials f...[Read more]
Industry
Biotechnology
IPO Date
2020-10-29
Stock Exchange
NASDAQ
Ticker
GLTO
According to Galecto, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.78. This represents a change of 566.67% compared to the average of -0.27 of the last 4 quarters.
The mean historical PE Ratio of Galecto, Inc. over the last ten years is -5.13. The current -1.78 PE Ratio has changed 3.37% with respect to the historical average. Over the past ten years (40 quarters), GLTO's PE Ratio was at its highest in in the December 2025 quarter at -0.04. The PE Ratio was at its lowest in in the December 2020 quarter at -20.10.
Average
-5.13
Median
-0.99
Minimum
-20.07
Maximum
-0.15
Discovering the peaks and valleys of Galecto, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.21%
Maximum Annual PE Ratio = -0.15
Minimum Annual Increase = -83.70%
Minimum Annual PE Ratio = -20.07
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.15 | -42.01% |
| 2024 | -0.25 | -49.70% |
| 2023 | -0.50 | 5.21% |
| 2022 | -0.47 | -67.94% |
| 2021 | -1.48 | -83.70% |
| 2020 | -9.07 | 0.02% |
| 2019 | -9.07 | -54.82% |
The current PE Ratio of Galecto, Inc. (GLTO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.30
5-year avg
-0.57
10-year avg
-5.13
Galecto, Inc.’s PE Ratio is less than TransCode Therapeutics, Inc. (-0.10), less than Phio Pharmaceuticals Corp. (-0.72), less than Aprea Therapeutics, Inc. (-0.41), less than Kiora Pharmaceuticals, Inc. (-0.95), less than IN8bio, Inc. (-0.38), less than Acurx Pharmaceuticals, Inc. (-0.31), less than Aptevo Therapeutics Inc. (-0.01), less than Lyra Therapeutics, Inc. (-0.02), less than Adial Pharmaceuticals, Inc. (-0.27), less than BioCardia, Inc. (-0.94),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.10 | $4.47M | |
| -0.72 | $11.97M | |
| -0.41 | $4.64M | |
| -0.95 | $11.21M | |
| -0.38 | $14.08M | |
| -0.31 | $2.44M | |
| -0.01 | $10.21M | |
| -0.02 | $781.13K | |
| -0.27 | $2.50M | |
| -0.94 | $5.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galecto, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galecto, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Galecto, Inc.'s PE Ratio?
How is the PE Ratio calculated for Galecto, Inc. (GLTO)?
What is the highest PE Ratio for Galecto, Inc. (GLTO)?
What is the 3-year average PE Ratio for Galecto, Inc. (GLTO)?
What is the 5-year average PE Ratio for Galecto, Inc. (GLTO)?
How does the current PE Ratio for Galecto, Inc. (GLTO) compare to its historical average?